Change in UACR over time by treatment arm at baseline, 6 months, and 1, 2, 3, and 4 years in the group of patients with baseline UACR ≤15 mg/g (A), baseline UACR >15 to <30 mg/g (B), baseline UACR ≥30 to ≤300 mg/g (C) and baseline UACR >300 mg/g (D), and in the group of patients with baseline eGFR ≥90 mL/min/1.73 m2 (E), baseline eGFR <90 to ≥60 mL/min/1.73 m2 (F), and baseline eGFR <60 mL/min/1.73 m2 (G). Shown are point estimates and 95% confidence intervals of geometric mean back-transformed to the original scale.